Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0U9MJ
|
||||
Former ID |
DIB000593
|
||||
Drug Name |
Melanoma vaccine
|
||||
Synonyms |
NA17.A2 peptides, Institut Curie; Vaccine (melanoma), Institut Curie; Melanoma vaccine (NA17.A2/tyrosinase/MART-1, gp100); Melanoma vaccine (NA17.A2/tyrosinase/MART-1, gp100), Institut Curie
|
||||
Drug Type |
Vaccine
|
||||
Indication | Melanoma [ICD9: 172; ICD10:C43] | Phase 3 | [521514] | ||
Company |
Institut Curie
|
||||
Target and Pathway | |||||
Target(s) | Tyrosine oxidase | Target Info | [550463] | ||
Melanocytes lineage-specific antigen GP100 | Target Info | [550463] | |||
MART-1 melanoma antigen | Target Info | [550463] | |||
PathWhiz Pathway | Riboflavin Metabolism | ||||
Tyrosine Metabolism | |||||
WikiPathways | Dopamine metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.